Pharmaceutical Advertising Advisory Board
Formation1976 (1976)
HeadquartersPickering, Ontario
Websitehttps://www.paab.ca/

The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario. Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals.[1][2] It is financed on a fee-for-service basis.

It works collaboratively with Health Canada, with the federal agency represented as an ex-oficio member on PAAB's board of directors.[3][4]

History

PAAB originated in 1976 through a collaboration between the Pharmaceutical Manufacturing Association of Canada and the Canadian Medical Association.[1][5] Within its first year, the organization had two staff members and had reviewed some 400 applications. As of July 1977, all advertisements printed in the Canadian Medical Association Journal carried the PAAB seal of approval following an examination of their quality and accuracy.[5] In 2004, PAAB's Patient Material Code was revised to include materials provided to patients by healthcare providers as well as adding regulations to standardize advertising over the internet.[1]

As of 2015, PAAB reported completing over 7,000 "first reviews" annually.[4]

Activities

Advertising materials for all health products in Canada that are intended for healthcare professionals are submitted for review and pre-clearance by PAAB, who prescribes the guidelines for direct marketing to this group.[6] Educational materials and other messaging directed towards consumers on prescription drugs and the medical conditions they treat are reviewed by PAAB and Advertising Standards Canada to ensure compliance with regulatory requirements.[2] While these reviews are not mandatory, PAAB is obligated to forward all safety-related complaints to Health Canada.[7]

Organization

Governance

Board of directors

PAAB is governed by a board of 12 members, including representation from industry associations Innovative Medicines Canada, BIOTECanada, Association of Medical Advertising Agencies, Canadian Association of Medical Publisher and Consumer Health Products Canada.[1][8][9]

Notable former members of the board include Susan Eng, former Chair of the Canadian Association of Retired Persons.[4]

Clients

Clients of PAAB include pharmaceutical companies and advertising agencies working on behalf of pharmaceutical interests.[1][10]

References

  1. 1 2 3 4 5 "PAAB : About". Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité Pharmaceutique. Archived from the original on 2018-09-24. Retrieved 2022-08-29.
  2. 1 2 Health Canada (2015-05-12). "Regulatory Requirements for Advertising". Government of Canada. Archived from the original on 2022-08-29. Retrieved 2022-08-29.
  3. ↑ Hearn, Bill; Zborovski, Sara (2015-07-07). "The International Comparative Legal Guide To Pharmaceutical Advertising". Mondaq. Retrieved 2022-09-01.
  4. 1 2 3 Khambatta, Richard; Integrated Pharma Services (July 2015). "PAAB Preclearance Review Mechanism: Audit Report Summary" (PDF). Pharmaceutical Advertising Advisory Board. Archived (PDF) from the original on 2022-09-01. Retrieved 2022-09-01.
  5. 1 2 Geekie, D.A. (1977-05-07). "Pharmaceutical Advertising Advisory Board and advertising in the Journal". Canadian Medical Association Journal. 116 (9): 968. ISSN 0008-4409. PMC 1879061. PMID 20312852.
  6. ↑ Harris, Kelly (2020-03-31). "In brief: prohibited and controlled advertising in Canada". Lexology. Archived from the original on 2022-08-30. Retrieved 2022-08-30.
  7. ↑ Dakin, Pauline (2014-12-10). "Prescription drug ad law notable for 'lack of teeth'". CBC News. Archived from the original on 2014-12-11. Retrieved 2022-08-29.
  8. ↑ Lexchin, Joel (2018-04-12). "How Big Pharma deceives you about drug safety". The Conversation. Archived from the original on 2021-10-16. Retrieved 2022-08-30.
  9. ↑ Kingston, Anne (2018-05-11). "A criminal investigation into opioid marketing would expose larger systemic rot". Maclean's. Archived from the original on 2022-08-30. Retrieved 2022-08-30.
  10. ↑ "PAAB : About". Pharmaceutical Advertising Advisory Board. Archived from the original on 2018-01-08. Retrieved 2022-08-30.{{cite web}}: CS1 maint: unfit URL (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.